McCarter M - Search Results

1

The risk of major elective vascular surgical procedures in patients with end-stage renal disease.

Gajdos C, Hawn MT, Kile D, Henderson WG, Robinson T, McCarter M, Nehler M. Gajdos C, et al. Among authors: mccarter m. Ann Surg. 2013 Apr;257(4):766-73. doi: 10.1097/SLA.0b013e3182686b87. Ann Surg. 2013. PMID: 22982978

2

Dendritic cells as therapeutic adjuncts in surgical disease.

Clarke JH, Cha JY, Walsh MD, Harken AH, McCarter MD. Clarke JH, et al. Surgery. 2005 Nov;138(5):844-50. doi: 10.1016/j.surg.2005.02.003. Surgery. 2005. PMID: 16291384 Review. No abstract available.

3

Combined thermal-surgical ablation of locally advanced abdominopelvic malignancies.

Gajdos C, Macdermott T, McCarter MD, Pearlman NW. Gajdos C, et al. Ann Surg Oncol. 2011 May;18(5):1267-73. doi: 10.1245/s10434-010-1467-4. Epub 2010 Dec 21. Ann Surg Oncol. 2011. PMID: 21174157

4

Debulking surgery in advanced melanoma.

Gajdos C, McCarter MD. Gajdos C, et al. Expert Rev Anticancer Ther. 2011 Nov;11(11):1703-12. doi: 10.1586/era.11.98. Expert Rev Anticancer Ther. 2011. PMID: 22050019 Review.

5

Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition.

Cheng SS, Nordenholz K, Matero D, Pearlman N, McCarter M, Gajdos C, Hamiel C, Baer A, Luzier E, Tran ZV, Olson T, Queensland K, Lutz R, Wischmeyer P. Cheng SS, et al. Among authors: mccarter m. Intensive Care Med. 2012 Apr;38(4):642-8. doi: 10.1007/s00134-011-2453-4. Epub 2012 Jan 10. Intensive Care Med. 2012. PMID: 22231174 Clinical Trial.

6

A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes.

Kounalakis N, Gao D, Gonzalez R, Becker M, Lewis K, Poust J, Pearlman N, Robinson W, McCarter M. Kounalakis N, et al. Among authors: mccarter m. Immunotherapy. 2012 Jul;4(7):679-86. doi: 10.2217/imt.12.62. Immunotherapy. 2012. PMID: 22853754 Free PMC article.

7

Sequential radiofrequency ablation and surgical debulking for unresectable colorectal carcinoma: thermo-surgical ablation.

Ripley RT, Gajdos C, Reppert AE, Macdermott T, McCarter MD, Pearlman NW. Ripley RT, et al. J Surg Oncol. 2013 Feb;107(2):144-7. doi: 10.1002/jso.23211. Epub 2012 Aug 23. J Surg Oncol. 2013. PMID: 22927225

8

Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.

Jones EL, Jones TS, Pearlman NW, Gao D, Stovall R, Gajdos C, Kounalakis N, Gonzalez R, Lewis KD, Robinson WA, McCarter MD. Jones EL, et al. JAMA Surg. 2013 May;148(5):456-61. doi: 10.1001/jamasurg.2013.1335. JAMA Surg. 2013. PMID: 23325294 Free PMC article.

9

Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.

DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, von Mehren M, McCarter MD, Norton J, Maki RG, Pisters PW, Demetri GD, Brennan MF, Owzar K; American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team for the Alliance for Clinical Trials in Oncology. DeMatteo RP, et al. Among authors: mccarter md. Ann Surg. 2013 Sep;258(3):422-9. doi: 10.1097/SLA.0b013e3182a15eb7. Ann Surg. 2013. PMID: 23860199 Free PMC article. Clinical Trial.

10

Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study.

Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD. Paniccia A, et al. Medicine (Baltimore). 2014 Dec;93(27):e198. doi: 10.1097/MD.0000000000000198. Medicine (Baltimore). 2014. PMID: 25501072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page